180 related articles for article (PubMed ID: 21308366)
1. Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys.
Jerome C; Missbach M; Gamse R
Osteoporos Int; 2011 Dec; 22(12):3001-11. PubMed ID: 21308366
[TBL] [Abstract][Full Text] [Related]
2. Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys.
Jerome C; Missbach M; Gamse R
Osteoporos Int; 2012 Jan; 23(1):339-49. PubMed ID: 21380636
[TBL] [Abstract][Full Text] [Related]
3. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
Bone; 2016 May; 86():43-52. PubMed ID: 26921823
[TBL] [Abstract][Full Text] [Related]
4. Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey.
Cusick T; Chen CM; Pennypacker BL; Pickarski M; Kimmel DB; Scott BB; Duong LT
J Bone Miner Res; 2012 Mar; 27(3):524-37. PubMed ID: 22113921
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cathepsin K increases modeling-based bone formation, and improves cortical dimension and strength in adult ovariectomized monkeys.
Pennypacker BL; Chen CM; Zheng H; Shih MS; Belfast M; Samadfam R; Duong LT
J Bone Miner Res; 2014 Aug; 29(8):1847-58. PubMed ID: 24591096
[TBL] [Abstract][Full Text] [Related]
6. Effects of raloxifene on bone density, biomarkers, and histomorphometric and biomechanical measures in ovariectomized cynomolgus monkeys.
Lees CJ; Register TC; Turner CH; Wang T; Stancill M; Jerome CP
Menopause; 2002; 9(5):320-8. PubMed ID: 12218720
[TBL] [Abstract][Full Text] [Related]
7. Treatment with a potent cathepsin K inhibitor preserves cortical and trabecular bone mass in ovariectomized monkeys.
Stroup GB; Kumar S; Jerome CP
Calcif Tissue Int; 2009 Oct; 85(4):344-55. PubMed ID: 19763376
[TBL] [Abstract][Full Text] [Related]
8. Effects of eight-month treatment with ONO-5334, a cathepsin K inhibitor, on bone metabolism, strength and microstructure in ovariectomized cynomolgus monkeys.
Ochi Y; Yamada H; Mori H; Nakanishi Y; Nishikawa S; Kayasuga R; Kawada N; Kunishige A; Hashimoto Y; Tanaka M; Sugitani M; Kawabata K
Bone; 2014 Aug; 65():1-8. PubMed ID: 24784023
[TBL] [Abstract][Full Text] [Related]
9. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
[TBL] [Abstract][Full Text] [Related]
10. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Pirie CM; Simmons HA; Chidsey-Frink KL; Chen HK; Jee WS; Thompson DD
Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783
[TBL] [Abstract][Full Text] [Related]
11. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
12. Cortical bone mineral density is increased by the cathepsin K inhibitor ONO-5334, which leads to a robust increase in bone strength: results from a 16-month study in ovariectomised cynomolgus monkeys.
Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Tanaka M; Deacon S; Kawabata K
J Bone Miner Metab; 2019 Jul; 37(4):636-647. PubMed ID: 30357565
[TBL] [Abstract][Full Text] [Related]
13. The effects of bazedoxifene in the ovariectomized aged cynomolgus monkey.
Smith SY; Jolette J; Chouinard L; Komm BS
J Bone Miner Metab; 2015 Mar; 33(2):161-72. PubMed ID: 24633538
[TBL] [Abstract][Full Text] [Related]
14. Minodronic acid ameliorates vertebral bone strength by increasing bone mineral density in 9-month treatment of ovariectomized cynomolgus monkeys.
Tanaka M; Mori H; Kawabata K; Mashiba T
Bone; 2016 Jul; 88():157-164. PubMed ID: 27155564
[TBL] [Abstract][Full Text] [Related]
15. Potential role of odanacatib in the treatment of osteoporosis.
Ng KW
Clin Interv Aging; 2012; 7():235-47. PubMed ID: 22866001
[TBL] [Abstract][Full Text] [Related]
16. Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys.
Duong LT; Pickarski M; Cusick T; Chen CM; Zhuo Y; Scott K; Samadfam R; Smith SY; Pennypacker BL
Bone; 2016 Jul; 88():113-124. PubMed ID: 27126999
[TBL] [Abstract][Full Text] [Related]
17. Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib.
Rünger TM; Adami S; Benhamou CL; Czerwiński E; Farrerons J; Kendler DL; Mindeholm L; Realdi G; Roux C; Smith V
J Am Acad Dermatol; 2012 Mar; 66(3):e89-96. PubMed ID: 21571394
[TBL] [Abstract][Full Text] [Related]
18. Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis).
Jerome CP; Burr DB; Van Bibber T; Hock JM; Brommage R
Bone; 2001 Feb; 28(2):150-9. PubMed ID: 11182372
[TBL] [Abstract][Full Text] [Related]
19. Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate.
Williams DS; McCracken PJ; Purcell M; Pickarski M; Mathers PD; Savitz AT; Szumiloski J; Jayakar RY; Somayajula S; Krause S; Brown K; Winkelmann CT; Scott BB; Cook L; Motzel SL; Hargreaves R; Evelhoch JL; Cabal A; Dardzinski BJ; Hangartner TN; Duong LT
Bone; 2013 Oct; 56(2):489-96. PubMed ID: 23806798
[TBL] [Abstract][Full Text] [Related]
20. Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys.
Hotchkiss CE; Stavisky R; Nowak J; Brommage R; Lees CJ; Kaplan J
Bone; 2001 Jul; 29(1):7-15. PubMed ID: 11472885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
